BillionToOne, Inc.
NASDAQ:BLLN · NASDAQ Global Select
+$0.84 today
Vol 0.99M · Avg 0.59M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
1.6%
avg -98.2%
ROIC
2.6%
avg -17.7%
ROA
1.2%
avg -18.6%
Analysis
ROIC is currently the strongest return metric at 2.6% versus its period average of -17.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Oguzhan Atay | Co-Founder, Chairman & Chief Executive Officer | $518,397.00 | — | 37 | — | — |
David Tsao | Co-Founder, President, Chief Technology Officer & Director | $460,784.00 | — | 36 | — | — |
Ross Taylor Jr. | Chief Financial Officer | $450,697.00 | — | 63 | — | — |
John D. Lister | Chief Administrative Officer | $441,464.00 | — | 51 | — | — |
Nancy Johnson | Senior Vice President of Sales & Commercial Operations | $406,750.00 | — | 62 | — | — |
Brent Kirk | Vice President of Sales Strategy & Operations | — | — | — | — | — |
Thomas Lynch | Chief Compliance Officer, General Counsel & Secretary | — | — | 59 | — | — |
Shan Riku Sakakibara | Chief Product Officer | — | — | 42 | — | — |
Gary Palmer | Chief Medical Officer of Oncology | — | — | 75 | — | — |
John ten Bosch FACMG | Senior Vice President of Laboratory Operations | — | — | 50 | — | — |
Jaclyn | Vice President of Marketing | — | — | — | — | — |
Judy Wong | VP & Controller | — | — | — | — | — |
Vaghar Haghiri | Senior Director of People Operations | — | — | — | — | — |
Haywood L. Brown | Chief Medical Officer for Prenatal | — | — | — | — | — |
Jean Hayden | Vice President of Business Operations & Chief of Staff | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | +91.5% (5yr)1 analysts |
| Revenue | N/A | N/A | N/A | +22.3% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | +58.7% (5yr)2 analysts |
| EBIT | N/A | N/A | N/A | +113.8% (5yr)2 analysts |
Analysis
Forward estimates point to EBIT at +113.8% (5yr), giving you a quick read on expected growth from here.
Competitors
Peer companies in the same sector
No competitor data available.
Who manages BLLN?
BillionToOne, Inc. (BLLN) lists 15 active executives. The top listed executive is Brent Kirk, Vice President of Sales Strategy & Operations.
Explore More
Continue the stock analysis
Jump to another research area for this company.